Cho Mu-Yeol, Eom Je-Hyun, Choi Eun-Mi, Yang Seung-Jo, Lee Dahye, Kim Young Youn, Kim Hye-Sung, Hwang Inseong
Apple Tree Institute of Biomedical Science, Apple Tree Medical Foundation, Goyang-si, South Korea.
DOCSmedi, Co., Ltd., Goyang-si, South Korea.
Clin Microbiol Rev. 2025 Jun 12;38(2):e0024024. doi: 10.1128/cmr.00240-24. Epub 2025 Apr 22.
SUMMARYRecent advances in therapeutic probiotics have shown promising results across various health conditions, reflecting a growing understanding of the human microbiome's role in health and disease. However, comprehensive reviews integrating the diverse therapeutic effects of probiotics in human subjects have been limited. By analyzing randomized controlled trials (RCTs) and meta-analyses, this review provides a comprehensive overview of key developments in probiotic interventions targeting gut, liver, skin, vaginal, mental, and oral health. Emerging evidence supports the efficacy of specific probiotic strains and combinations in treating a wide range of disorders, from gastrointestinal (GI) and liver diseases to dermatological conditions, bacterial vaginosis, mental disorders, and oral diseases. We discuss the expanding understanding of microbiome-organ connections underlying probiotic mechanisms of action. While many clinical trials demonstrate significant benefits, we acknowledge areas requiring further large-scale studies to establish definitive efficacy and optimal treatment protocols. The review addresses challenges in standardizing probiotic research methodologies and emphasizes the importance of considering individual variations in microbiome composition and host genetics. Additionally, we explore emerging concepts such as the oral-gut-brain axis and future directions, including high-resolution microbiome profiling, host-microbe interaction studies, organoid models, and artificial intelligence applications in probiotic research. Overall, this review offers a comprehensive update on the current state of therapeutic probiotics across multiple domains of human health, providing insights into future directions and the potential for probiotics to revolutionize preventive and therapeutic medicine.
治疗性益生菌的最新进展在各种健康状况下都显示出了令人鼓舞的结果,这反映出人们对人类微生物组在健康和疾病中的作用有了越来越深入的了解。然而,综合整合益生菌在人体中的多种治疗效果的综述一直很有限。通过分析随机对照试验(RCT)和荟萃分析,本综述全面概述了益生菌干预在肠道、肝脏、皮肤、阴道、精神和口腔健康方面的关键进展。新出现的证据支持特定益生菌菌株和组合在治疗多种疾病方面的有效性,从胃肠道(GI)和肝脏疾病到皮肤病、细菌性阴道病、精神障碍和口腔疾病。我们讨论了对益生菌作用机制背后的微生物组与器官联系的不断扩展的理解。虽然许多临床试验显示出显著益处,但我们也认识到需要进一步进行大规模研究以确定确切疗效和最佳治疗方案的领域。该综述探讨了益生菌研究方法标准化方面的挑战,并强调了考虑微生物组组成和宿主遗传学个体差异的重要性。此外,我们还探索了诸如口腔 - 肠道 - 脑轴等新兴概念以及未来方向,包括高分辨率微生物组分析、宿主 - 微生物相互作用研究、类器官模型以及人工智能在益生菌研究中的应用。总体而言,本综述全面更新了治疗性益生菌在人类健康多个领域的当前状况,为未来方向以及益生菌彻底改变预防和治疗医学的潜力提供了见解。